In the first half of 2022, Bosnalijek, the largest pharmaceutical company in Bosnia and Herzegovina, made record profit before tax of BAM 20.7 million, an increase by BAM 18.9 million compared to the same period of the previous year. The profit is the result of the successfully implemented strategy and activities of the management and employees of Bosnalijek.

With investment valued at 50 million convertible marks (BAM), Bosnalijek will see fivefold increase in its production capacities. This modern production plant ensures the reputation of a manufacturer with the highest quality standards.